Decreased glucose tolerance, not decreased insulin sensitivity, is a maturational abnormality in the male offspring of a parent with early coronary artery disease

Metabolism: Clinical and Experimental

Volumn 46, Issue 5, 1997, Pages 504-512

  Slyper, Arnold H ^a   Zvereva, Svetlana ^b   Pleuss, Joan ^b   Hoffmann, Raymond G ^b   Myers, Thomas ^b   Walker, John A ^b  

^a Midwest Athletes Against Childhood Cancer Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROGENESIS; CORONARY ARTERY DISEASE; CORONARY RISK; FAMILY HISTORY; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGENY;

EID: 0030979036     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90185-2     Document Type: Article

References (84)

1. Stout RW: Insulin and atheroma. 20-yr perspective. Diabetes Care 13:631-654, 1990
2. Young MH, Jeng C-Y, Sheu WH-H, et al: Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 72:458-460, 1993
3. Shinozaki K, Suzuki M, Ikebuchi M, et al: Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 19:1-7, 1996
4. Laakso M, Sarlund H, Salonen R, et al: Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 11:1068-1076, 1991
5. Reaven GM, Chen Y-DI: Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 4:639-652, 1988
6. Reaven GM, Laws A: Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 37:948-952, 1994
7. Zavaroni I, Dall'Aglio E, Alpi O, et al: Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55:259-266, 1985
8. Jeppesen J, Hollenbeck CB, Zhou M-Y, et al: Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb 15:320-324, 1995
9. Schrezenmeir J, Keppler I, Fenselau S, et al: The phenomenon of a high triglyceride response to an oral lipid load in healthy subjects and its link to the metabolic syndrome. Ann NY Acad Sci 683:302-314, 1993
10. Selby JV, Austin MA, Newman B, et al: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88:381-387, 1993
11. Reaven GM, Chen Y-DI, Jeppesen J, et al: Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92:141-146, 1993
12. Wingard DL, Barrett-Connor EL, Ferrara A: Is insulin really a heart disease risk factor? Diabetes Care 18:1299-1304, 1995
13. Ducimetiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
14. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2:154-160, 1979
15. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care 2:131-141, 1979
16. Fontbonne A, Charles MA, Thibult N, et al: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15 year follow-up. Diabetologia 34:356-361, 1991
17. Cullen K, Stenhouse NS, Wearne KL, et al: Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia - 13-year study. J Chronic Dis 36:371-377, 1983
18. Hargreaves AD, Logan RL, Elton RA, et al: Glucose tolerance, plasma insulin, HDL cholesterol and obesity; 12-year follow-up and development of coronary artery disease in Edinburgh men. Atherosclerosis 94:61-69, 1992
19. Rewers M, Shetterly SM, Baxter J, et al: Insulin and cardiovascular disease in Hispanics and non-Hispanic whites (NHW): The San Luis Valley Diabetes Study. Circulation 85:865, 1992 (abstr)
20. Yarnell JWG, Sweetnam PM, Marks V, et al: Insulin in ischaemic heart disease: Are associations explained by triglyceride concentrations? The Caerphilly Prospective Study. Br Heart J 71:293-296, 1994
21. Orchard TJ, Eichner J, Kuller LH, et al: Insulin as a predictor of coronary heart disease: Interaction with apolipoprotein phenotype. A report from the Multiple Risk Factor Intervention Study. Ann Epidemiol 4:40-45, 1994
22. Kuusisto J, Mykkanen L, Pyorala K, et al: Hyperinsulinemic microalbuminemia: a new risk indicator for coronary heart disease. Circulation 91:831-837, 1995
23. Ferrara A, Barrett-Connor E, Edelstein SL: Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: The Rancho Bemado Study, 1984 to 1991. Am J Epidemiol 140:857-869, 1994
24. Bergman RN, Beard JC, Chen M: The minimal modeling method. Assessment of insulin sensitivity and B-cell function in vivo, in Clarke WL, Lamer J, Pohl SL (eds): Methods in Diabetes Research, vol 2: Clinical Methods. New York, NY, Wiley, 1986, pp 15-34
25. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86, 1985
26. Schumaker VN, Puppione DL: Sequential flotation ultracentrifugation. Methods Enzymol 128:155-170, 1986
27. Winer BJ: Statistical Principles in Experimental Design. New York, NY, McGraw-Hill, 1971
28. Yamashita S, Nakamura T, Shimomura I, et al: Insulin resistance and body fat distribution. Contribution of visceral fat accumulation to the development of insulin resistance and atherosclerosis. Diabetes Care 19:287-291, 1996
29. Hauner H, Stangl K, Schmatz C, et al: Body fat distribution in men with angiographically confirmed coronary artery disease. Atherosclerosis 85:203-210, 1990
30. Larsson B, Svardsudd K, Welin L, et al: Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 288:1401-1404, 1984
31. Lapidus L, Bengtsson C, Larsson B, et al: Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 289:1257-1261, 1984
32. Cefalu WT, Wang ZQ, Werbel S, et al: Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 44:954-959, 1995
33. Despres J-P: Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9:452-459, 1993
34. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382-386, 1991
35. Kissebah AH, Peiris AN: Biology of regional body fat distribution: Relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83-109, 1989
36. Suehiro T, Ohguro T, Sumiyoshi R. et al: Relationship of low-density lipoprotein particle size to plasma lipoproteins, obesity, and insulin resistance in Japanese men. Diabetes Care 18:333-338, 1995
37. Frayn KN, Coppack SW: Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 82:1-8, 1992
38. Bjorntorp P: "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496, 1990
39. Kotani K, Tokunaga K, Fujioka S, et al: Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes 18:207-212, 1994
40. Borkan GA, Hults DE, Gerzof SG, et al: Age changes in body composition revealed by computed tomography. J Gerontol 38:673-677, 1983
41. Enzi G, Gasparo M, Biondetti PR, et al: Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 44:739-746, 1986
42. Matsuzawa Y, Shimomura I, Nakamura T, et al: Pathophysiology and pathogenesis of visceral fat obesity. Ann NY Acad Sci 748:399-406, 1995
43. Hartz AJ, Rupley DC, Rimm AA: The association of girth measurements with disease in 32,856 women. Am J Epidemiol 119:71-80, 1984
44. Bjorntorp P: Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:615-622, 1988
45. Laws A, Stefanick ML, Reaven GM: Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:343-347, 1989
46. Osei K, Cottrell DA, Orabella MM: Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care 14:890-896, 1991
47. Haffner SM, Stern MP, Hazuda HP, et al: Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319:1297-1301, 1988
48. Ho LT, Chang ZY, Wang JT, et al: Insulin insensitivity in offspring of parents with type 2 diabetes mellitus. Diabetic Med 7:31-34, 1990
49. Warram JH, Martin BC, Krolewski AS, et al: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:909-915, 1990
50. Ramachandran A, Snehalatha C, Mohan V, et al: Decreased insulin sensitivity in offspring whose parents both have type 2 diabetes. Diabetic Med 7:331-334, 1990
51. Leslie RDG, Ganash A, Volkmann HP, et al: Insensitivity to insulin in offspring of non-insulin dependent diabetic patients. Diab Nutr Metab 3:235-237, 1988
52. Gelding SV, Niththyananthan R, Chan S-P, et al: Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups. Clin Endocrinol (Oxf) 40:55-62, 1994
53. Henriksen JE, Alford F, Handberg A, et al: Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 94:1196-1204, 1994
54. O'Rahilly SO, Turner RC, Matthews DR: Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225-1230, 1988
55. Pimenta W, Korytkowski M, Mitrakou A, et al: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855-1861, 1995
56. Snehalatha C, Mohan V, Ramachandran A, et al: Pancreatic beta cell function in offspring of conjugal diabetic parents. Assessment by IRI and C-peptide ratio. Horm Metab Res 16:142-144, 1984
57. O'Rahilly SP, Rudenski AS, Burnett MA, et al: Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet 8501:360-364, 1986
58. Porte D Jr: Banting Lecture 1990. β-Cells in type II diabetes mellitus. Diabetes 40:166-180, 1991
59. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:334-337, 1989
60. Vaag A, Henriksen JE, Madsbad S, et al: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690-698, 1995
61. Polonsky KS, Sturis J, Bell GI: Non-insulin-dependent diabetes mellitus - A genetically programmed failure of the beta-cell to compensate for insulin resistance. N Engl J Med 334:777-783, 1996
62. Haffner SM, Miettinen H, Stern MP: Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes. J Clin Endocrinol Metab 81:1846-1851, 1996
63. Fujimoto WY, Leonetti DL, Newell-Morris L, et al: Relationship of absence or presence of a family history of diabetes to body weight and body fat distribution in type 2 diabetes. Int J Obes 15:111-120, 1991
64. Lemieux S, Despres J-P, Nadeau A, et al: Heterogenous glycaemic and insulinaemic responses to oral glucose in non-diabetic men: Interactions between duration of obesity, body fat distribution and family history of diabetes mellitus. Diabetologia 35:653-659, 1992
65. Shuman WP, Morris NLL, Leonetti DL, et al: Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 21:483-487, 1986
66. Gray DS, Fujioka K, Colletti PM, et al: Magnetic-resonance imaging used for determining fat distribution in obesity and diabetes. Am J Clin Nutr 54:623-627, 1991
67. Ferrari P, Weidmann P, Shaw S, et al: Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 91:589-596, 1991
68. Facchini F, Chen Y-DI, Clinkingbeard C, et al: Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 5:694-699, 1992
69. Ohno Y, Suzuki H, Yamakawa H, et al: Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: Possible role of disturbed calcium metabolism. J Hypertens 11:421-426, 1993
70. Endre T, Mattiasson I, Hulthen UL, et al: Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens 12:81-88, 1994
71. Beatty OL, Harper R, Sheridan B, et al: Insulin resistance in offspring of hypertensive parents. Br Med J 307:92-96, 1993
72. Grunfeld B, Balzareti M, Romo M, et al: Hyperinsulinemia in normotensive offspring of hypertensive parents. Hypertension 23:112-115, 1994 (suppl 1)
73. Alleman Y, Horber FF, Colombo M, et al: Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 341:327-331, 1993
74. Abel ED, Ledingham JG: Impaired glucose tolerance in hypetension is associated with impaired insulin release independently of changes in insulin sensitivity. J Hypertens 12:1265-1273, 1994
75. Fujioka S, Matsuzawa Y, Tokunaga K, et al: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54-59, 1987
76. Sparrow D, Borkan GA, Gerzof SG, et al: Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the normative aging study. Diabetes 35:411-415, 1986
77. Bonora E, del Prato S, Bonadonna RC, et al: Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 41:1151-1159, 1992
78. Pouliot M-C, Despres J-P, Nadeau A, et al: Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
79. Pacini G, Valerio A, Beccaro F, et al: Insulin sensitivity and beta-cell responsivity are not decreased in elderly subjects with normal OGTT. J Am Geriatr Soc 36:317-323, 1988
80. Couet C, Delarue J, Constans T, et al: Age-related insulin resistance: A review. Horm Res 38:46-50, 1992
81. Chen M, Bergman RN, Pacini G, et al: Pathogenesis of age-related glucose intolerance in man: Insulin resistance and decreased β-cell function. J Clin Endocrinol Metab 60:13-20, 1985
82. Pagano G, Cassader M, Cavallo-Perin P, et al: Insulin resistance in the aged: A quantitative evaluation of in vivo insulin sensitivity and in vitro glucose transport. Metabolism 33:976-981, 1984
83. Rowe JW, Minaker KL, Pallotta JA: Characterization of the insulin resistance of aging. J Clin Invest 71:1581-1583, 1983
84. Fink RI, Kolterman OG, Griffin J, et al: Mechanisms of insulin resistance in aging. J Clin Invest 71:1523-1535, 1983